45
Views
0
CrossRef citations to date
0
Altmetric
Corrigendum

Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma [Corrigendum]

Page 1709 | Published online: 21 Mar 2017
This article refers to:
Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma

Xu J, Liu X, Yang S, Zhang X, Shi Y. OncoTargets and Therapy. 2016;9:2911–2917.

On page 2911, the affiliation was listed as Department of Internal Medicine, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China. It should have been Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China.